Auna (NYSE:AUNA) Announces Quarterly Earnings Results, Misses Estimates By $0.11 EPS

Auna (NYSE:AUNA) posted its quarterly earnings results on Tuesday. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.11), Zacks reports. Auna had a net margin of 1.53% and a return on equity of 16.25%.

Auna Stock Up 2.0%

Shares of AUNA traded up $0.11 during midday trading on Tuesday, reaching $5.49. 460,978 shares of the stock were exchanged, compared to its average volume of 348,364. The company has a market cap of $406.04 million, a price-to-earnings ratio of 21.10 and a beta of 0.61. The company has a quick ratio of 1.00, a current ratio of 1.09 and a debt-to-equity ratio of 1.76. Auna has a 12-month low of $4.09 and a 12-month high of $6.85. The firm has a 50 day simple moving average of $5.14 and a 200-day simple moving average of $5.11.

Analysts Set New Price Targets

AUNA has been the subject of a number of research reports. JPMorgan Chase & Co. decreased their price objective on Auna from $6.00 to $5.00 and set a “neutral” rating for the company in a research report on Tuesday, May 26th. Wall Street Zen lowered shares of Auna from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 5th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Auna in a report on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $6.97.

Insider Activity at Auna

In related news, Director John Wilton sold 17,574 shares of the firm’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $4.17, for a total transaction of $73,283.58. Following the transaction, the director owned 49,974 shares of the company’s stock, valued at approximately $208,391.58. This trade represents a 26.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, President Leon Jesus Zamora bought 6,420 shares of Auna stock in a transaction on Friday, May 29th. The stock was acquired at an average price of $4.15 per share, with a total value of $26,643.00. Following the completion of the purchase, the president directly owned 69,130 shares of the company’s stock, valued at approximately $286,889.50. The trade was a 10.24% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last three months, insiders purchased 83,454 shares of company stock valued at $357,063.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of AUNA. Virtu Financial LLC raised its holdings in shares of Auna by 43.5% during the 4th quarter. Virtu Financial LLC now owns 16,029 shares of the company’s stock valued at $79,000 after purchasing an additional 4,856 shares in the last quarter. XTX Topco Ltd acquired a new stake in shares of Auna in the 4th quarter valued at $162,000. Occudo Quantitative Strategies LP bought a new stake in Auna in the fourth quarter worth $84,000. Millennium Management LLC boosted its holdings in Auna by 115.2% in the fourth quarter. Millennium Management LLC now owns 26,475 shares of the company’s stock worth $130,000 after purchasing an additional 14,170 shares in the last quarter. Finally, Squarepoint Ops LLC acquired a new position in Auna during the fourth quarter worth $196,000.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.